Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Xoma Corp. other research news

XOMA (Berkeley) published findings on the 23-kilodalton rBPI protein showing that it contains three functional binding domains, pointing the way for additional clinical applications of the

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE